| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 抗病毒类(元) | 3,315,513.52 | 9,670,316.03 | 4,521,368.35 | 8,736,658.05 | 3,848,896.25 |
| 抗生素类(元) | 14,239,224.94 | 35,369,547.66 | 17,560,804.64 | 37,014,447.76 | 14,939,303.56 |
| 利尿剂类(元) | 1,655,513.97 | 2,520,224.56 | 1,043,180.15 | 1,623,453.85 | 352,193.52 |
| 免疫调节类(元) | 3,467,143.53 | 5,426,678.03 | 2,483,034.18 | 4,513,683.79 | 1,871,532.73 |
| 消化类(元) | 422,299.08 | 7,854,175.50 | 4,625,353.79 | 8,709,013.22 | 4,395,771.51 |
| 心脑血管类(元) | 245,355,288.71 | 563,548,816.48 | 268,836,321.87 | 427,777,185.12 | 202,821,102.35 |
| 原料药及中间体(元) | 1,903,097.36 | 9,936,046.46 | 5,196,575.50 | 7,566,955.76 | 2,803,415.91 |
| 锂电池电解液添加剂(元) | 91,020,280.92 | 27,652,559.39 | - | - | - |
| 其他(元) | 1,592,150.06 | 3,816,844.43 | 1,745,196.98 | 6,166,479.21 | 4,427,181.96 |
| 营业成本(元) | |||||
| 抗病毒类(元) | 4,522,299.41 | 9,784,496.92 | 3,954,909.35 | - | 2,931,549.80 |
| 抗生素类(元) | 5,930,778.08 | 11,814,002.27 | 5,232,686.31 | - | 3,755,866.06 |
| 利尿剂类(元) | 603,785.76 | 744,372.54 | 290,820.44 | - | 163,105.55 |
| 免疫调节类(元) | 739,814.78 | 1,456,236.12 | 775,625.83 | - | 591,313.57 |
| 消化类(元) | 275,015.85 | 6,129,859.82 | 3,306,427.47 | - | 2,880,318.80 |
| 心脑血管类(元) | 18,443,928.21 | 39,251,785.64 | 20,374,143.75 | 35,739,715.41 | 17,848,304.69 |
| 原料药及中间体(元) | 1,658,658.63 | 10,641,007.14 | 5,035,426.19 | - | 2,275,910.24 |
| 锂电池电解液添加剂(元) | 55,517,425.57 | 23,488,538.66 | - | - | - |
| 其他(元) | 1,186,095.16 | 3,470,275.30 | 1,512,507.75 | - | 4,058,622.15 |
| 毛利(元) | |||||
| 抗病毒类(元) | -1,206,785.89 | -114,180.89 | 566,459.00 | - | 917,346.45 |
| 抗生素类(元) | 8,308,446.86 | 23,555,545.39 | 12,328,118.33 | - | 11,183,437.50 |
| 利尿剂类(元) | 1,051,728.21 | 1,775,852.02 | 752,359.71 | - | 189,087.97 |
| 免疫调节类(元) | 2,727,328.75 | 3,970,441.91 | 1,707,408.35 | - | 1,280,219.16 |
| 消化类(元) | 147,283.23 | 1,724,315.68 | 1,318,926.32 | - | 1,515,452.71 |
| 心脑血管类(元) | 226,911,360.50 | 524,297,030.84 | 248,462,178.12 | 392,037,469.71 | 184,972,797.66 |
| 原料药及中间体(元) | 244,438.73 | -704,960.68 | 161,149.31 | - | 527,505.67 |
| 锂电池电解液添加剂(元) | 35,502,855.35 | 4,164,020.73 | - | - | - |
| 其他(元) | 406,054.90 | 346,569.13 | 232,689.23 | - | 368,559.81 |
| 毛利率(%) | |||||
| 抗病毒类(%) | -36.40 | -1.18 | 12.53 | - | 23.83 |
| 抗生素类(%) | 58.35 | 66.60 | 70.20 | - | 74.86 |
| 利尿剂类(%) | 63.53 | 70.46 | 72.12 | - | 53.69 |
| 免疫调节类(%) | 78.66 | 73.17 | 68.76 | - | 68.40 |
| 消化类(%) | 34.88 | 21.95 | 28.52 | - | 34.48 |
| 心脑血管类(%) | 92.48 | 93.03 | 92.42 | 91.65 | 91.20 |
| 原料药及中间体(%) | 12.84 | -7.09 | 3.10 | - | 18.82 |
| 锂电池电解液添加剂(%) | 39.01 | 15.06 | - | - | - |
| 其他(%) | 25.50 | 9.08 | 13.33 | - | 8.32 |
| 收入构成(%) | |||||
| 抗病毒类(%) | 0.91 | 1.45 | 1.48 | 1.74 | 1.63 |
| 抗生素类(%) | 3.92 | 5.31 | 5.74 | 7.37 | 6.34 |
| 利尿剂类(%) | 0.46 | 0.38 | 0.34 | 0.32 | 0.15 |
| 免疫调节类(%) | 0.96 | 0.82 | 0.81 | 0.90 | 0.79 |
| 消化类(%) | 0.12 | 1.18 | 1.51 | 1.73 | 1.87 |
| 心脑血管类(%) | 67.60 | 84.64 | 87.85 | 85.20 | 86.14 |
| 原料药及中间体(%) | 0.52 | 1.49 | 1.70 | 1.51 | 1.19 |
| 锂电池电解液添加剂(%) | 25.08 | 4.15 | - | - | - |
| 其他(%) | 0.44 | 0.57 | 0.57 | 1.23 | 1.88 |
| 毛利构成(%) | |||||
| 抗病毒类(%) | -0.44 | -0.02 | 0.21 | 0.00 | 0.46 |
| 抗生素类(%) | 3.03 | 4.21 | 4.64 | 0.00 | 5.57 |
| 利尿剂类(%) | 0.38 | 0.32 | 0.28 | 0.00 | 0.09 |
| 免疫调节类(%) | 1.00 | 0.71 | 0.64 | 0.00 | 0.64 |
| 消化类(%) | 0.05 | 0.31 | 0.50 | 0.00 | 0.75 |
| 心脑血管类(%) | 82.79 | 93.79 | 93.57 | 100.00 | 92.05 |
| 原料药及中间体(%) | 0.09 | -0.13 | 0.06 | 0.00 | 0.26 |
| 锂电池电解液添加剂(%) | 12.95 | 0.74 | - | - | - |
| 其他(%) | 0.15 | 0.06 | 0.09 | 0.00 | 0.18 |